For the Inventor, By the Inventor

Enter assignee name

Cambridge, MA, United States of America

Sirna Therapeutics, Inc.

USPTO Granted Patents = 138

CIPO Patents = 18

EPO Patents = 46

Forward Citations = 2,174

Loading Chart...

Loading Chart...

151 inventors (with patents filed for the assignee):

Leonid Beigelman (51 out of 224 patents)

James A McSwiggen (37 out of 99 patents)

Matthew G Stanton (30 out of 69 patents)

4. Chandra Vargeese (25 out of 54 patents)

5. Weimin Wang (21 out of 27 patents)

6. Steven L Colletti (18 out of 40 patents)

7. Duncan F Brown (15 out of 33 patents)

8. Brian W Budzik (9 out of 12 patents)

9. Walter R Strapps (9 out of 19 patents)

10. Vasant R Jadhav (9 out of 46 patents)

11. Aarron T Willingham (9 out of 9 patents)

12. Lu Tian (9 out of 9 patents)

13. Jasenka Matulic-Adamic (9 out of 29 patents)

14. David M Tellers (8 out of 21 patents)

15. Denise M Kenski (8 out of 10 patents)

Core Competencies:

RNA Interference

Short Interfering Nucleic Acids

Oligonucleotide Delivery

Cationic Lipids

Chemically Modified siNA

Tetragalnac Conjugates

Micro RNA Mimetics

Prolyl Hydroxylase Domain Inhibition

Hepatitis B Virus Inhibition

Biodegradable Cationic Lipids

Myostatin Inhibition

Catenin Gene Expression

138 patents: Sort by Forward Citations

1. 12304925 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2025-05-20),

2. 11952573 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2024-04-09),

3. 11932854 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2024-03-19),

4. 11911475 - Low molecular weight cationic lipids for oligonucleotide delivery (2024-02-27),

5. 11530407 - Short interfering nucleic acid (siNA) compositions (2022-12-20),

6. 11193126 - RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA) (2021-12-07),

7. 11117917 - Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides (2021-09-14),

8. 10889815 - RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) (2021-01-12),

9. 10793860 - RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA) (2020-10-06),

10. 10738308 - Short interfering nucleic acid (siNA) molecules containing a 2' internucleoside linkage (3dT) (2020-08-11),

11. 10729787 - Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety (2020-08-04),

12. 10689648 - Short interfering nucleic acid (siNA) compositions (2020-06-23),

13. 10662428 - RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) (2020-05-26),

14. 10584335 - Single-stranded RNAi agents containing an internal, non-nucleic acid spacer (2020-03-10),

15. 10577606 - RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA) (2020-03-03),

SIRNA THERAPEUTICS, INC. is a biotechnology company focused on the discovery and development of RNA-based therapeutics. The company uses RNA interference (RNAi) technology to target and silence specific genes involved in various diseases. SIRNA aims to deliver innovative RNAi therapeutics that can provide new treatments for a wide range of medical conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

138 Patents

#19 in Cambridge, MA

#147 in Massachusetts

#2,712 in US

#5,700 in the World

Cambridge, MA, United States of America

Sirna Therapeutics, Inc.

Forward Citations = 2,174

151 inventors:

Leonid Beigelman (51 out of 224 patents)

James A McSwiggen (37 out of 99 patents)

Matthew G Stanton (30 out of 69 patents)

4. Chandra Vargeese (25 out of 54 patents)

5. Weimin Wang (21 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…